The trial’s first phase will begin in university hospitals across the Netherlands, Denmark, Germany and Sweden.
Fintel reports that on March 17, 2025, Leerink Partners initiated coverage of Nurix Therapeutics (NasdaqGM:NRIX) with a ...
Orphan Drug Designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenström MacroglobulinemiaFirst-in-class ...
Shares of Nuvation Bio Inc. (NYSE:NUVB – Get Free Report) have been assigned an average recommendation of “Buy” from the six ratings firms that are covering the company, Marketbeat Ratings reports.